Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

3.9%

5 terminated/withdrawn out of 127 trials

Success Rate

84.8%

-1.7% vs industry average

Late-Stage Pipeline

24%

31 trials in Phase 3/4

Results Transparency

4%

1 of 28 completed trials have results

Key Signals

21 recruiting1 with results

Enrollment Performance

Analytics

N/A
38(44.2%)
Phase 4
20(23.3%)
Phase 3
11(12.8%)
Phase 1
8(9.3%)
Phase 2
6(7.0%)
Early Phase 1
3(3.5%)
86Total
N/A(38)
Phase 4(20)
Phase 3(11)
Phase 1(8)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (127)

Showing 20 of 127 trials
NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07603115Not Yet Recruiting

Diagnostic Study of Structural Heart Disease Based on Cardiac Electromechanical Signals

Role: collaborator

NCT07538882Recruiting

AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma

Role: collaborator

NCT06065046Phase 2Recruiting

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Role: collaborator

NCT06429527Not ApplicableEnrolling By Invitation

Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07385131Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Role: collaborator

NCT07353385Not ApplicableCompleted

Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains

Role: lead

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Role: collaborator

NCT07346456Completed

Comparison of IOL Formulas in Eyes With PCE≥15µm

Role: lead

NCT07305675Not ApplicableCompleted

Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment of Atrophic Acne Scars.

Role: lead

NCT07250581Not ApplicableRecruiting

A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation

Role: collaborator

NCT07160361Phase 4Not Yet Recruiting

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

Role: lead

NCT07173517Not Yet Recruiting

Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

Role: collaborator

NCT07153679Not ApplicableCompleted

Efficacy and Safety of a 1064-nm Nd:YAG Picosecond Laser Versus a 1927-nm Fractional Laser for Atrophic Acne Scars.

Role: lead

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT07093411Early Phase 1Recruiting

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Role: collaborator

NCT07107308Not ApplicableActive Not Recruiting

Efficacy and Safety Evaluation of Microfocused Ultrasound Combined With 1550 nm Non-Ablative Fractional Laser for Facial Rejuvenation

Role: lead

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT06558877Not ApplicableRecruiting

Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients

Role: collaborator